已收盘 02-06 16:00:00 美东时间
+2.320
+3.26%
Travel + Leisure Co. Opens New Global Headquarters in Downtown Orlando Travel + Leisure Co. has officially opened its new global headquarters at 501 W. Church St. in Downtown Orlando. The relocation, marked by a ribbon-cutting ceremony with local leaders and partners, reflects the company’s commitme
01-22 04:31
今日重点评级关注:Guggenheim:维持MBX Biosciences"买入"评级,目标价从77美元升至88美元;摩根士丹利:维持DraftKings"超配"评级,目标价从50美元升至53美元
01-20 10:26
Morgan Stanley analyst Stephen Grambling maintains Travel+Leisure (NYSE:TNL) with a Overweight and raises the price target from $68 to $80.
01-17 01:31
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
Barclays analyst Brandt Montour upgrades Travel+Leisure (NYSE:TNL) from Underweight to Equal-Weight and raises the price target from $63 to $70.
2025-12-17 22:46
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
2025-11-19 11:01
花旗上调Bilibili目标价升至27美元; 摩根士丹利上调英伟达目标价升至220美元;Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
Truist Securities analyst Patrick Scholes maintains Travel+Leisure (NYSE:TNL) with a Buy and raises the price target from $70 to $71.
2025-11-15 01:51
今日重点评级关注:摩根士丹利:维持Viking Therapeutics"超配"评级,目标价从98美元升至102美元;摩根大通:维持IDEAYA Biosciences"超配"评级,目标价从74美元升至79美元
2025-10-24 09:51
ARMP大涨超103%!抗血感染药物在中期试验中显示出积极结果;直觉外科公司涨近14%,Q3业绩表现优异,远超市场预期>>
2025-10-23 14:51